Key Drivers
- Gross Margin
- Cash Burn
- Leverage Risk
AIAI Summary
ESTA has shifted from a “growth story” to a “prove-it execution story”: strong U.S. revenue momentum and early adjusted EBITDA improvement are real, but persistent negative free cash flow, elevated leverage, and a broken technical structure mean investors should only get more constructive if the company can sustain growth, convert it into consistent profitability, and defend the 74–75 support area.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Gross Margin
- •Cash Burn
- •Leverage Risk
ESTA has strong gross margins and near-term liquidity, but persistent operating losses, negative free cash flow, and very high leverage make it a risky, expensive turnaround.
Price Behavior
Key Price Behavior Insights:
- •Support break
- •Mid-$70s defense
- •Weak bounce
ESTA remains technically weak after breaking support and sliding into the mid-$70s, with $74-$75 now the key level that must hold for any base to form.
Sharp drop from $94.61 to $74.28 broke prior support and shifted rallies into selling zones
Sentiment & News
Key News Insights:
- •U.S. Expansion
- •Margin Leverage
- •Loss Still
Establishment Labs posted strong Q2 revenue growth and accelerating U.S. sales, but ongoing losses and a slight EPS miss keep the focus on scaling toward profitability.
The results are modestly positive for sentiment as growth momentum improves, but sustained losses may limit near-term upside until operating leverage becomes clearer
Similar Companies in Healthcare
Other companies in the same sector with AI ratings